AXIM Biotechnologies Competitors and Similar CompaniesClear all
AXIM Biotechnologies's competitors and similar companies include Versea and Zynerba.
 AXIM Biotechnologies AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. |  Versea Versea Holdings is a pharmaceutical company focused on the development of molecules for the treatment of inflammatory and other debilitating diseases. |  Zynerba Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. | |
Founding Date | Founding Date 2010 | Founding Date 2018 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations New York, US HQ San Diego, US | Locations Tampa, US HQ Belfast, GB Tampa, US | Locations Devon, US HQ |
Employees | Employees 6 | Employees 393% decrease | Employees 2511% decrease |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) N/A | Valuation ($) 70.1 m |
Financial | |||
Net income | Net income ($8.1m) (FY, 2023) | Net income N/A | Net income ($35m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 115k | Total funding raised N/A | Total funding raised $ 16.5m |
For sources of this data, please see the company profile
View Company Profiles
Versea
HQ
Tampa, US
Employees
39↓ 3% decrease
Versea Holdings is a pharmaceutical company focused on the development of molecules for the treatment of inflammatory and other debilitating diseases.
View companyZynerba
HQ
Devon, US
Employees
25↓ 11% decrease
Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.
View company